[Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
The characteristic pathological changes of Parkinson  s disease (PD) include a severe loss of dopamine neurons in the substantia nigra and a severe decrease in dopamine in the striatum. Since the expression of tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC) in the biosynthetic pathway for dopamine are low, a promising approach to the gene therapy of PD is to augment the gene expression of the enzymes in the biosynthetic pathway for dopamine. In the present study, human TH and AADC genes were reconstructed into retrovirous vectors pLHCX and pLNCX(2) respectively. Then pLHCX/TH and pLNCX(2)/AADC were transfected into packaging cell line PA317 with liposome. PA317/TH and PA317/AADC were selected by different antibiotics. Gene expression was examined by methods of immunohistochemistry and in situ hybridization. The catalytic activity of two cloned gene enzymes was assessed in vitro by HPLC-EC. Immunocytochemical staining showed that TH and AADC were expressed efficiently in vitro. Both TH and AADC mRNA were transcripted in PA317 cell lines by using in situ hybridazation. HPLC-EC experiments revealed that the transfected cells produced a significantly higher level of dopamine and L-dopa than the untransfected cells. The two genetically modified cells could improve the production of L-dopa and dopamine in response to suitable substrate. The present results suggest that not only recombinant TH and AADC genes are successfully expressed in vitro, but also the enzymes have respective functional activities. These results have set up a way for in vivo gene therapy of PD with TH and AADC genes.
Su
Yue
Y
Beijing Institute for Neuroscience, Beijing Center for Neural Regeneration and Repair, Capital University of Medical Sciences Beijing 100054.
Duan
Chun-Li
CL
Zhao
Chun-Li
CL
Zhao
Huan-Ying
HY
Xu
Qun-Yuan
QY
Yang
Hui
H
D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism; D002460:Cell Line; D003342:Corpus Striatum / Q000201:enzymology; D004298:Dopamine / Q000096:biosynthesis; D015870:Gene Expression; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007980:Levodopa / Q000096:biosynthesis*; D010300:Parkinson Disease / Q000201:enzymology / Q000235:genetics*; D012333:RNA, Messenger / Q000096:biosynthesis; D013378:Substantia Nigra / Q000378:metabolism; D014162:Transfection; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism
D012333:RNA, Messenger; D007980:Levodopa; D014446:Tyrosine 3-Monooxygenase; D001142:Aromatic-L-Amino-Acid Decarboxylases; D004298:Dopamine